EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Corticosteroids for Acute Respiratory Distress Syndrome

Riccardo Guglielmi, Antonio Campanella, Jesús Villar, Antoni Torres, Carlos Ferrando

Seminars in Respiratory and Critical Care Medicine · 01.02.2026 · 47 (01) · 098-110

DOI: 10.1055/a-2721-6094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.02.2026. Verfasst von Riccardo Guglielmi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Glucocorticoids, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 100 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) remains a heterogeneous and a major challenge disease process despite five decades of study. Emerging translational data delineate three overlapping phases: exudative, proliferative, and fibroproliferative, each driven by distinct immune–mechanical pathways and potentially modifiable by glucocorticosteroids (GC) modulation. Contemporary clinical randomized trials and meta-analyses indicate that early (≤72 hours) administration of systemic GCs at receptor-saturating doses (e.g., dexamethasone from 20 to 10 mg/day, or methylprednisolone 1–2 mg/kg/day) accelerates resolution of pulmonary edema, shortens mechanical ventilation duration, and improves intensive care survival, while prolonged tapering regimens are required once fibroproliferation is established. Conversely, delayed initiation (>14 days), viral pneumonitis with high viral load, recent surgical anastomosis, or uncontrolled fungal coinfection constitute “red flags” in which GCs might increase mortality. Latent-class analyses—a statistical modeling approach in which multivariable data are reduced to indirectly observed (latent) variables—identified two (hyper- and hypoinflammatory) ARDS phenotypes that likely might respond differentially to GC exposure, although we lack validation studies. Therefore, it seems that biomarker-guided precision therapy is poised to replace the historical one-size-fits-all approach. This narrative review integrates epidemiology, pathobiology, pharmacology, and clinical evidence to provide a phase-specific, phenotype-directed framework for GC use in ARDS and outlines future research priorities aimed at harmonizing molecular endotyping with dose, timing, and tapering strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress SyndromeGlucocorticoidsAdrenal Cortex HormonesHumansRespiration, Artificial

Substanzen

GlucocorticoidsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
  • Biomedical Research Networking Center in Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Medicine, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
  • Multidisciplinary Research Group in Intensive Care (GREMCI), Research Unit, Hospital Universitario Dr. Negrín, Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria, Spai…
  • Faculty of Health Sciences, Universidad del Atlántico Medio, Tafira Baja, Las Palmas de Gran Canaria, Spain.
  • Department of Anesthesiology and Critical Care Medicine, Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.

Zitieren

APA

Guglielmi, R., Campanella, A., Villar, J., Torres, A., & Ferrando, C. (2026). Corticosteroids for Acute Respiratory Distress Syndrome. Seminars in Respiratory and Critical Care Medicine, 47(01), 098-110. https://doi.org/10.1055/a-2721-6094

Vancouver

Guglielmi R, Campanella A, Villar J, Torres A, Ferrando C. Corticosteroids for Acute Respiratory Distress Syndrome. Seminars in Respiratory and Critical Care Medicine. 2026;47(01):098-110. doi:10.1055/a-2721-6094

BibTeX
@article{Guglielmi2026,
  author = {Guglielmi, Riccardo and Campanella, Antonio and Villar, Jesús and Torres, Antoni and Ferrando, Carlos},
  title = {Corticosteroids for Acute Respiratory Distress Syndrome},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2026},
  volume = {47},
  number = {01},
  pages = {098--110},
  doi = {10.1055/a-2721-6094}
}
Kostenlos starten →